SJS Investment Consulting’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.86K Buy
1,727
+1,339
+345% +$5.59K ﹤0.01% 1553
2026
Q2
$1.63K Buy
388
+83
+27% +$320 ﹤0.01% 1853
2026
Q1
$1.07K Buy
305
+284
+1,352% +$1.16K ﹤0.01% 1439
2025
Q4
$71 Buy
+21
New +$55 ﹤0.01% 1987
2024
Q3
– Sell
-5
Closed -$33 – 1684
2024
Q2
$33 Sell
5
-20
-80% -$141 ﹤0.01% 1638
2024
Q1
$218 Hold
25
– – ﹤0.01% 1469
2023
Q4
$286 Buy
25
+1
+4% +$10 ﹤0.01% 1390
2023
Q3
$232 Sell
24
-1
-4% -$10 ﹤0.01% 1430
2023
Q2
$266 Sell
25
-8
-24% -$86 ﹤0.01% 1347
2023
Q1
$348 Buy
33
+4
+14% +$45 ﹤0.01% 1252
2022
Q4
$359 Sell
29
-23
-44% -$261 ﹤0.01% 1302
2022
Q3
$0 Buy
+52
New +$590 ﹤0.01% 1275
2022
Q1
$0 Buy
+4
New +$46 ﹤0.01% 1019

Other funds holding IRWD

SJS Investment Consulting's IRWD Position: Q3 2026 in Review

SJS Investment Consulting increased its Ironwood Pharmaceuticals (IRWD) stake by 345% in Q3 2026, buying an estimated $5.59K and bringing the position to 1,727 shares worth $6.86K. The position accounts for ﹤0.01% of the portfolio, ranked #1553.

SJS Investment Consulting first reported a position in IRWD in Q1 2022 and has held it in 13 quarters since. 50 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

  • SJS Investment Consulting held 1,727 shares of Ironwood Pharmaceuticals worth $6.86K as of Q3 2026.
  • SJS Investment Consulting bought 1,339 Ironwood Pharmaceuticals shares in Q3 2026, an estimated $5.59K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #1553 holding.
  • SJS Investment Consulting first reported a position in Ironwood Pharmaceuticals in Q1 2022 and has held it in 13 quarters since.
  • 50 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.